Search results
Results from the WOW.Com Content Network
Agreement with the Court's judgment does not guarantee agreement with the reasoning expressed in its opinion. A justice is not considered in agreement if they dissented even in part. Agreement percentages are based only on the listed cases in which a justice participated and are rounded to the nearest one-tenth of one percentage point.
Whether the U.S. Court of Appeals for the 5th Circuit erred in setting aside FDA’s denial orders of respondents' applications for authorization to market new e-cigarette products as arbitrary and capricious. July 2, 2024: December 2, 2024 Feliciano v. Department of Transportation: 23-861
Trump's team asked the Supreme Court to reject the expedited timeline and allow the appeals court to consider the case first. [29] [30] On December 22, the Supreme Court denied the special counsel's request, leaving the case to the appeals court. [31] On January 9, 2024, the D.C. Court of Appeals heard arguments in the immunity dispute.
The nation’s highest court will weigh in on a challenge to the FDA’s approval of the drug Mifepristone ruling – latest: Supreme Court decision keeps medical abortion pill approval in place ...
The New York-based Danco Laboratories, which makes mifepristone, said the U.S. Supreme Court decision on Thursday “safeguards access to a drug that has decades of safe and effective use.”
The Supreme Court confirmed the draft's authenticity the next day; at the same time, the Supreme Court's press release said that "it does not represent a decision by the Court or the final position of any member on the issues in the case". [103] [104] [105] In response to the leak, Roberts said, "The work of the Court will not be affected in ...
(The Center Square) – A unanimous ruling by the U.S. Supreme Court may pave the way for challenges to a federal deportation plan under the incoming Trump administration to be defeated. The ...
New York State Rifle & Pistol Association, Inc. v. Bruen, 597 U.S. 1 (2022), abbreviated NYSRPA v. Bruen and also known as NYSRPA II or Bruen to distinguish it from the 2020 case, is a landmark decision [1] [2] [3] of the United States Supreme Court related to the Second Amendment to the United States Constitution.